Shingo Nakayamada

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Interstitial Lung Disease

Intellectual Disability

Systemic Lupus Erythematosus

Top Venues

Rheumatology and therapy

Expert review of clinical immunology

Modern rheumatology case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Hidenori Sakai, Yusuke Miyazaki, Shingo Nakayamada, Yasuyuki Todoroki, Kentaro Hanami, Shunsuke Fukuyo, Ayako Yamaguchi, Ippei Miyagawa, Masanobu Ueno, Hiroaki Tanaka, Yasuyuki Todoroki, Naoaki Ohkubo, Masashi Funada, Satsuki Matsunaga, Yoshiya Tanaka
Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry. Rheumatology (Oxford, England) (2024)
Shingo Nakayamada, Yoshiya Tanaka
Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus. Biomolecules 13 (6) (2023)
Shingo Nakayamada, Yoshiya Tanaka
Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus. Biomolecules 13 (6) (2023)
Satoshi Kubo, Shingo Nakayamada, Yoshiya Tanaka
JAK inhibitors for rheumatoid arthritis. Expert opinion on investigational drugs (2023)
Shingo Nakayamada, Yoshiya Tanaka
Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus. Biomolecules 13 (6) (2023)
Shingo Nakayamada, Yoshiya Tanaka
Pathological relevance and treatment perspective of JAK targeting in systemic lupus erythematosus. Expert review of clinical immunology 18 (3) (2022)
Katsuhide Kusaka, Ippei Miyagawa, Shunpei Kosaka, Satsuki Matsunaga, Shingo Nakayamada, Yoshiya Tanaka
A case of glucocorticoid-resistant adult Still's disease complicated by pulmonary hypertension and interstitial lung disease. Modern rheumatology case reports (2022)
Shingo Nakayamada, Yoshiya Tanaka
Clinical relevance of T follicular helper cells in systemic lupus erythematosus. Expert review of clinical immunology 17 (10) (2021)